At ADMA Biologics, we believe in recognizing the exceptional contributions of our team members! ?? Our annual LEAP Awards celebrate those who embody the core values of Leadership ??, Entrepreneurship ??, Accountability ??, and Professionalism ??. This year, we're thrilled to share some highlights from our LEAP Award Luncheon, where we honored the outstanding individuals nominated by their peers. Our distinguished LEAP award winners earned a special all-expense-paid trip ?? to one of eight beautiful US cities ???, with the unique opportunity to attend an Immune Deficiency Foundation Patient Advocacy walk ??, alongside a friend or partner. Join us in congratulating our LEAP Award recipients who continue to drive innovation and excellence in our mission to improve patient lives! ??? #ADMABiologics #LEAPAwards #EmployeeRecognition #CompanyCulture
关于我们
ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA) approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM? (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV? (immune globulin intravenous, human – slra 10% liquid) for the treatment of PI; and NABI-HB? (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides a portion of its blood plasma for the manufacture of its products. ADMA’s mission is to manufacture, market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283, 9,815,886, 9,969,793 and 10,259,865 related to certain aspects of its products and product candidates. For more information, please visit www.admabiologics.com.
- 网站
-
https://www.admabiologics.com
ADMA Biologics, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 501-1,000 人
- 总部
- Ramsey，NJ
- 类型
- 上市公司
- 创立
- 2004
- 领域
- Plasma Collection、Plasma Products、Pharmaceutical Manufacturing、Biologics、Biotechnology、Immune Deficiency和Infectious Disease
地点
ADMA Biologics, Inc.员工
-
Alison Finger
Global C-Suite | Biotech | COO | CCO | Board Director | R&D | Commercial | Biotech Advisor | Company Builder
-
Lucy DeMario
Senior Director Scientific & Data Analysis at ADMA Biologics, Inc.
-
Jessica Hensley, MBA
-
Kestas Parakininkas
Im an talented out of the box think, extremely quick learner, and accomplished problem solver. I am not afraid of jumping into deep water to learn…
动态
-
As promised, here are additional photos from our "Spooktacular Halloween" celebration at ADMA Biologics! ?? Our team showcased some of the most incredibly creative costumes, proving once again that we’re not just coworkers, but a family that knows how to have fun together.?It’s moments like these that highlight the camaraderie and joy we share in our vibrant workplace A huge thank you to everyone who participated and made this Halloween special! We loved every minute of it and can’t wait to celebrate more fun moments together! ?? hashtag #TeamSpirit #WorkFamily #ADMA
-
"???? ADMA Biologics is celebrating Halloween in style! Our dedicated team is having a fang-tastic time with spooky decorations, super creative costumes, and treats galore. Wishing everyone a safe and fun-filled night of frights and delights! ?????♂? Happy Halloween from our team to yours! More to come as we compile all the great photos! ??????? #HappyHalloween #ADMAHalloween #SpookySeason"
-
-
-
-
-
+2
-
-
Just wrapped up an incredible week at the #ACAAI 2024 Annual Scientific Meeting in Boston! ??? Huge appreciation to the attending clinicians, speakers and our amazing #ADMABiologics team for their commitment ??. This week was filled with valuable insights, hands-on discussions ???, and exciting developments in immunoglobulin therapy ??. Together, at #ADMABiologics we’re advancing a new age of revolutionary specialty biologic products! Each step forward brings us closer to a brighter future for patients with primary immunodeficiency?? #ACAAI2024 #ADMA #IVIG #PrimaryImmunodeficiency #Collaboration #Teamwork?
-
-
Register to watch Maeve O'Connor MD and Christopher Chang, MD, PhD, discuss “Practical Approaches to Recurrent Respiratory Infections in Patients With Primary Immunodeficiency” https://cvent.me/Ebm31P #ACAAI2024 #ADMA
-
-
Thank you to the clinicians ????????, the organizers at #IgNS, and our dedicated team at #ADMABiologics for their commitment at this year's #IgNS Annual Meeting ??. We had great scientific sessions and dialogue with healthcare professionals ??, shared our innovations ??, and explored advancements in treating patients with primary immunodeficiency. Together, we continue our mission to improve the lives of the immune compromised ??. #IgNS #ADMA #IVIG #PID #Teamwork
-
-
Register to watch Maeve Edel O'Connor MD discuss “Personalizing IgRT in Clinical Practice to Address Recurrent Respiratory Infections in PI” bit.ly/adma_igns24 #IgNS2024 #ADMA
-
-
?? Exciting times at #ADMA Biologics! Congratulations to Robert Brooks and our dedicated internal team, along with our amazing consulting partners at #tcgmcube, for the successful rollout of #ADMAlytics?— a game changer in how we utilize AI to improve efficiency across our organization. Our journey of innovation continues, as we leverage machine learning and natural language processing to streamline processes and optimize production, creating significant cost savings and enhancing operational excellence. Curious to learn more about how ADMA is using generative AI to transform biologics manufacturing? Check out the article below!?? https://lnkd.in/eefG_RrH #ADMAPride #InnovationInAction #GenerativeAI #Biotech #Biologics #Efficiency #MachineLearning #Teamwork #AI
-
This International Plasma Awareness Week, ADMA Biologics proudly recognizes and thanks our incredible team—thank you for being a "Lifesaver"! To show our appreciation, we're sharing Lifesaver candies as a small symbol of the vital role you play in delivering life-saving plasma-derived therapies. Your dedication, passion, and tireless efforts make a profound impact on patients' lives every day. We are deeply grateful for your unwavering commitment to excellence. You are the heartbeat of ADMA! #IPAW2024 #PlasmaAwareness #LifeSavers #ADMABiologics #Gratitude #IVIG
-
-
??? Celebrating International Plasma Awareness Week! ??? ?At #ADMABiologics, we recognize the life-saving power of #plasma and the vital role it plays in advancing healthcare. From supporting patients with immune deficiencies to ensuring the availability of essential therapies, plasma donation is a beacon of hope for so many. ? Thank you to all #plasmadonors, healthcare professionals, and our incredible team for your unwavering commitment to improving lives. Together, we’re making a difference every day! Learn more during #IPAW2024 at www.plasmaweek.org. #PlasmaAwareness #SavingLives #ADMA #PlasmaDonation #Healthcare #ThankYouDonors #IVIG #PIDD
-